Danaher Extends Offer for Beckman Coulter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher announced late on Tuesday that it has extended its offer to buy Beckman Coulter to expire at midnight EDT April 27.

The offer had been set to expire at midnight EDT today. All other terms and conditions of Danaher's $6.8 billion bid for Beckman Coulter are unchanged.

The deal is expected to close during the second quarter, Danaher said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.